Sutro Biopharma reports Q3 2026 results, advances ADC pipeline and Astellas collaboration
Sutro says STRO-004 and STRO-006 are both in the clinic, STRO-227 is headed there in early 2027, and cash runs into first half of 2028.
SEC filing
2 stories
Sutro says STRO-004 and STRO-006 are both in the clinic, STRO-227 is headed there in early 2027, and cash runs into first half of 2028.
SEC filing